Adult Hemoglobinopathy Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064219
  • May 2021
  • Biotechnology
  • 135 Pages
The global Adult Hemoglobinopathy Testing market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Adult Hemoglobinopathy Testing market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Adult Hemoglobinopathy Testing market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Adult Hemoglobinopathy Testing market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Chromsystems Instruments and Chemicals GmbH, BioMedomics, Inc, CapitalBio Technology Inc, Trinity Biotech, Streck, Inc, Baxter, Bluebird Bio
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Adult Hemoglobinopathy Testing market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Adult Hemoglobinopathy Testing market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Adult Hemoglobinopathy Testing market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Adult Hemoglobinopathy Testing market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Adult Hemoglobinopathy Testing Market:
The Adult Hemoglobinopathy Testing market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Chromsystems Instruments and Chemicals GmbH, BioMedomics, Inc, CapitalBio Technology Inc, Trinity Biotech, Streck, Inc, Baxter, Bluebird Bio

Adult Hemoglobinopathy Testing Market Segment Analysis:
By Variant Type
Variant A2
Variant F
Test Type
HPLC Test
Mass spectrometry
Hb electrophoresis
End User
Hospitals
Reference Laboratories
Academic and Medical Institutes

Geographic Coverage for Adult Hemoglobinopathy Testing Market:
The market research report on global Adult Hemoglobinopathy Testing market offers complete analysis across various regions across the world. The Adult Hemoglobinopathy Testing market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Adult Hemoglobinopathy Testing market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Adult Hemoglobinopathy Testing Market Value and Forecast
  • US
  • Canada
Europe Adult Hemoglobinopathy Testing Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Adult Hemoglobinopathy Testing Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Adult Hemoglobinopathy Testing Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Adult Hemoglobinopathy Testing Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Adult Hemoglobinopathy Testing market report:
  • The report provides key trends of the global Adult Hemoglobinopathy Testing market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Adult Hemoglobinopathy Testing industry
  • The report covers all the recent developments of the Adult Hemoglobinopathy Testing market and helps to provide current industry updates
  • The report covers a detailed look over the global Adult Hemoglobinopathy Testing Industry and provides with significant actionable insights
  • The Adult Hemoglobinopathy Testing market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Adult Hemoglobinopathy Testing market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Adult Hemoglobinopathy Testing market
  • Comprehensive analysis of the Adult Hemoglobinopathy Testing market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Adult Hemoglobinopathy Testing market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Adult Hemoglobinopathy Testing market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Adult Hemoglobinopathy Testing market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Adult Hemoglobinopathy Testing market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Adult Hemoglobinopathy Testing market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Chromsystems Instruments and Chemicals GmbH
  • BioMedomics, Inc
  • CapitalBio Technology Inc
  • Trinity Biotech
  • Streck, Inc
  • Baxter
  • Bluebird Bio
  • Variant A2
  • Variant F
  • Hospitals
  • Reference Laboratories
  • Academic and Medical Institutes

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Adult Hemoglobinopathy Testing Market Snapshot
          2.1.1. Global Adult Hemoglobinopathy Testing Market By Variant Type,2019
               2.1.1.1.Variant A2
               2.1.1.2.Variant F
          2.1.2. Global Adult Hemoglobinopathy Testing Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Reference Laboratories
               2.1.2.3.Academic and Medical Institutes
          2.1.3. Global Adult Hemoglobinopathy Testing Market By End-use,2019
          2.1.4. Global Adult Hemoglobinopathy Testing Market By Geography,2019

3. Global Adult Hemoglobinopathy Testing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Variant Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Variant Type, 2020
     4.2. Global Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028

5. Global Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028

6. Global Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028

7. Global Adult Hemoglobinopathy Testing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Adult Hemoglobinopathy Testing Market Analysis, 2018 – 2028 
          7.2.1. North America Adult Hemoglobinopathy Testing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028
          7.2.3. North America Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Adult Hemoglobinopathy Testing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Adult Hemoglobinopathy Testing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028
          7.3.3. Europe Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Adult Hemoglobinopathy Testing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Adult Hemoglobinopathy Testing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028
          7.4.3. Asia Pacific Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Adult Hemoglobinopathy Testing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Adult Hemoglobinopathy Testing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028
          7.5.3. Latin America Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Adult Hemoglobinopathy Testing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Adult Hemoglobinopathy Testing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Adult Hemoglobinopathy Testing Market Size (US$), By Variant Type, 2018 – 2028
          7.6.3. MEA Adult Hemoglobinopathy Testing Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Adult Hemoglobinopathy Testing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Adult Hemoglobinopathy Testing Providers
        8.4.1 Bio-Rad Laboratories, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Bio-Rad Laboratories, Inc. Geographic Operations
                8.4.1.3 Bio-Rad Laboratories, Inc. Financial Information
                8.4.1.4 Bio-Rad Laboratories, Inc. Product Positions/Portfolio
                8.4.1.5 Bio-Rad Laboratories, Inc. Key Developments
        8.4.2 Thermo Fisher Scientific Inc.
                8.4.2.1 Business Description
                8.4.2.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.2.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.2.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.2.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.3 PerkinElmer Inc.
                8.4.3.1 Business Description
                8.4.3.2 PerkinElmer Inc. Geographic Operations
                8.4.3.3 PerkinElmer Inc. Financial Information
                8.4.3.4 PerkinElmer Inc. Product Positions/Portfolio
                8.4.3.5 PerkinElmer Inc. Key Developments
        8.4.4 Chromsystems Instruments and Chemicals GmbH
                8.4.4.1 Business Description
                8.4.4.2 Chromsystems Instruments and Chemicals GmbH Geographic Operations
                8.4.4.3 Chromsystems Instruments and Chemicals GmbH Financial Information
                8.4.4.4 Chromsystems Instruments and Chemicals GmbH Product Positions/Portfolio
                8.4.4.5 Chromsystems Instruments and Chemicals GmbH Key Developments
        8.4.5 BioMedomics, Inc
                8.4.5.1 Business Description
                8.4.5.2 BioMedomics, Inc Geographic Operations
                8.4.5.3 BioMedomics, Inc Financial Information
                8.4.5.4 BioMedomics, Inc Product Positions/Portfolio
                8.4.5.5 BioMedomics, Inc Key Developments
        8.4.6 CapitalBio Technology Inc
                8.4.6.1 Business Description
                8.4.6.2 CapitalBio Technology Inc Geographic Operations
                8.4.6.3 CapitalBio Technology Inc Financial Information
                8.4.6.4 CapitalBio Technology Inc Product Positions/Portfolio
                8.4.6.5 CapitalBio Technology Inc Key Developments
        8.4.7 Trinity Biotech
                8.4.7.1 Business Description
                8.4.7.2 Trinity Biotech Geographic Operations
                8.4.7.3 Trinity Biotech Financial Information
                8.4.7.4 Trinity Biotech Product Positions/Portfolio
                8.4.7.5 Trinity Biotech Key Developments
        8.4.8 Streck, Inc
                8.4.8.1 Business Description
                8.4.8.2 Streck, Inc Geographic Operations
                8.4.8.3 Streck, Inc Financial Information
                8.4.8.4 Streck, Inc Product Positions/Portfolio
                8.4.8.5 Streck, Inc Key Developments
        8.4.9 Baxter
                8.4.9.1 Business Description
                8.4.9.2 Baxter Geographic Operations
                8.4.9.3 Baxter Financial Information
                8.4.9.4 Baxter Product Positions/Portfolio
                8.4.9.5 Baxter Key Developments
        8.4.10 Bluebird Bio
                8.4.10.1 Business Description
                8.4.10.2 Bluebird Bio Geographic Operations
                8.4.10.3 Bluebird Bio Financial Information
                8.4.10.4 Bluebird Bio Product Positions/Portfolio
                8.4.10.5 Bluebird Bio Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Adult Hemoglobinopathy Testing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Adult Hemoglobinopathy Testing Market Revenue, By Variant Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Adult Hemoglobinopathy Testing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Adult Hemoglobinopathy Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Adult Hemoglobinopathy Testing Market Revenue, By Variant Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Adult Hemoglobinopathy Testing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Adult Hemoglobinopathy Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Adult Hemoglobinopathy Testing Market Revenue, By Variant Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Adult Hemoglobinopathy Testing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Adult Hemoglobinopathy Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Adult Hemoglobinopathy Testing Market Revenue, By Variant Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Adult Hemoglobinopathy Testing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Adult Hemoglobinopathy Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Adult Hemoglobinopathy Testing Market Revenue, By Variant Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Adult Hemoglobinopathy Testing Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Adult Hemoglobinopathy Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Adult Hemoglobinopathy Testing: Market Segmentation 
FIG. 2 Global Adult Hemoglobinopathy Testing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Adult Hemoglobinopathy Testing Market, By Variant Type, 2019 (US$ Mn) 
FIG. 5 Global Adult Hemoglobinopathy Testing Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Adult Hemoglobinopathy Testing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Adult Hemoglobinopathy Testing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Adult Hemoglobinopathy Testing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Adult Hemoglobinopathy Testing Providers, 2019
FIG. 11 Global Adult Hemoglobinopathy Testing Market Revenue Contribution, By Variant Type, 2019 & 2028 (Value %) 
FIG. 12 Global Adult Hemoglobinopathy Testing Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Adult Hemoglobinopathy Testing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Adult Hemoglobinopathy Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Adult Hemoglobinopathy Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Adult Hemoglobinopathy Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Adult Hemoglobinopathy Testing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Adult Hemoglobinopathy Testing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Adult Hemoglobinopathy Testing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Adult Hemoglobinopathy Testing Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Adult Hemoglobinopathy Testing Market Value, By Segment1, 2018 – 2028
TABLE  North America Adult Hemoglobinopathy Testing Market Value, By Segment2, 2018 – 2028
TABLE  North America Adult Hemoglobinopathy Testing Market Value, By Country, 2018 – 2028
TABLE  Europe Adult Hemoglobinopathy Testing Market Value, By Segment1, 2018 – 2028
TABLE  Europe Adult Hemoglobinopathy Testing Market Value, By Segment2, 2018 – 2028
TABLE  Europe Adult Hemoglobinopathy Testing Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Adult Hemoglobinopathy Testing Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Adult Hemoglobinopathy Testing Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Adult Hemoglobinopathy Testing Market Value, By Country, 2018 – 2028
TABLE  Latin America Adult Hemoglobinopathy Testing Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Adult Hemoglobinopathy Testing Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Adult Hemoglobinopathy Testing Market Value, By Country, 2018 – 2028
TABLE  MEA Adult Hemoglobinopathy Testing Market Value, By Segment1, 2018 – 2028
TABLE  MEA Adult Hemoglobinopathy Testing Market Value, By Segment2, 2018 – 2028
TABLE  MEA Adult Hemoglobinopathy Testing Market Value, By Country, 2018 – 2028
TABLE  Bio-Rad Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PerkinElmer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chromsystems Instruments and Chemicals GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioMedomics, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CapitalBio Technology Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Trinity Biotech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Streck, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bluebird Bio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Adult Hemoglobinopathy Testing Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Adult Hemoglobinopathy Testing Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Adult Hemoglobinopathy Testing Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Adult Hemoglobinopathy Testing Market, By Geography, 2019 (US$ Mn)
FIG.  Global Adult Hemoglobinopathy Testing Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Adult Hemoglobinopathy Testing Providers, 2016
FIG.  Global Adult Hemoglobinopathy Testing Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Variant F Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Adult Hemoglobinopathy Testing Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Reference Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Academic and Medical Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Adult Hemoglobinopathy Testing Market Value, 2018 – 2028, (US$ Mn)